JP Morgan Chase’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ACHC
CCM
DM
DCM
FCM
ABI
JP Morgan Chase's ACHC Position: Q2 2026 in Review
JP Morgan Chase increased its Acadia Healthcare (ACHC) stake by 46% in Q2 2026, buying an estimated $1.09M and bringing the position to 135,820 shares worth $3.87M. The position accounts for ﹤0.01% of the portfolio, ranked #3673.
JP Morgan Chase first reported a position in ACHC in Q2 2013 and has held it in 53 quarters since. The position peaked at $341M in Q2 2017. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.
- JP Morgan Chase held 135,820 shares of Acadia Healthcare worth $3.87M as of Q2 2026.
- JP Morgan Chase bought 42,580 Acadia Healthcare shares in Q2 2026, an estimated $1.09M.
- Acadia Healthcare made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3673 holding.
- JP Morgan Chase first reported a position in Acadia Healthcare in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Acadia Healthcare position peaked at $341M in Q2 2017.
- 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.